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Following an intramuscular injection of isoniazid 3 mg/kg body-weight, the urinary
excretion of isoniazid and acetylisoniazid during the periods 0-1, 1-2, 2-3 and 3-4 h was
determined for 124 patients with pulmonary tuberculosis. On the same occasion, the
serum isoniazid concentration at 4½ h was determined by microbiologic assay. The ratios
of acetylisoniazid to isoniazid in the urine collections at 2, 3 and 4 h. were bimodally
distributed. Rules were derived from these. ratios for classifying subjects as slow or
rapid inactivators of isoniazid.There was 100% agreement between the classification
based on each of these ratios and that based on the serum isoniazid concentration at
4½ h.
Introduction
With the advent of intermittent regimens in the chemotherapy of tuberculosis,
the rate of inactivation of isoniazid has attained considerable importance (Tuberculosis
Chemotherapy Centre, Madras 1970). This rate is usually determined by estimating
the concentration of isoniazid in plasma or serum after oral, intramuscular or intra-
venous administration of the drug.The present paper describes a simpler method
requiring the collection of a single urine specimen after an intramuscular injection of
isoniazid. The method is based on the finding that slow inactivators of isoniazid
excrete a larger proportion of the dose in the free form and a smaller proportion as
acetylisoniazid (and isonicotinic acid) in the urine, than do rapid inactivators (Arm-
strong and Peart 1960, Mukoyama et al 1963, Peters et al 1965, Short 1962, Tiitinen
1969). The efficiency of this (urine) method was assessed in parallel with that of a
standard method based on microbiological assay of isoniazid in serum.
Material and Methods
Patients : In all, 124 patients with newly-diagnosed pulmonary tuberculosis, the latter
part of an intake of 241 to a chemotherapy study, were included in this investigation.
* This article is also being published in the Tubercle (Edin)
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2 Urine Test for Determining Isoniazid Inactivation Rate
Collection of specimens :On the day of the test, a specimen of urine was collected
from the patient and tested for acetylisoniazid by the method of Eidus and Hamilton
(1964). If the result was negative, the patient was given an intramuscular injection of
isoniazid, 3 mg/kg body-weight. Urine collections were made for the periods 0-l,
1-2, 2-3 and 3-4 h (and the volumes noted), and blood taken at 4½ h. Urine and
serum specimens were then stored at –20°C for periods not exceeding one week.
Estimation of isoniazid in serum :The concentration of isoniazid in serum was esti-
mated microbiologically, using a vertical diffusion method similar to that described
by Lloyd and Mitchison (1964) (The lower limit for the sensitivity of this method is
0.2 µg/ml).It took 2 weeks for the result to become available.
Estimation of isoniazid aud acetylisoniazid in urine : Estimations of isoniazid and
acetylisoniazid were undertaken on each urine collection.All the urine collections in
each week were examined at a single session, after coding and rearranging them in a
random order.
Isoniazid : Isoniazid was extracted by the method of Eidus and Little (1962) and was
estimated by the method of Maher et al (1957) with minor modifications.In brief,
3 ml of urine was first mixed with 1 ml of 0.1 N sodium hydroxide solution and 3.2 g of
powdered ammonium sulphate, and then shaken together with 30 ml of a solvent mixture
containing chloroform and n- butanol (7 : 3) for 30 min in a rotary shaker. Next,
20 ml of the solvent extract was shaken for 15 min with 4 ml of 0.1N sulphuric acid.
A 3 ml aliquot of the resulting acid extract was then treated with 0.3 ml of a 2 % vanillin
solution in 25 % ethanol, and the colour intensity read at 380 mµ in a Unicam SP 600
spectrophotometer.The concentrations of isoniazid were read from a standard
graph prepared with known concentrations of isoniazid.
Acetylisoniazid : Acetylisoniazid was estimated by the method of Venkataraman et l
(1968), without treatment with potassium permanganate, and expressed as equivalent
of isoniazid.
Results
Serum isoniazid concentrations :The distribution of patients according to the serum
isoniazid concentration at 4½ h after an intramuscular dose of 3 mg/kg is set out in
Graph 1. On the basis of this histogram, patients with a concentration of 0.90 µg/ml
or more were classified as slow inactivators of isoniazid, and those with a concentra-
tion of 0.89 µg/ml or less as rapid inactivators.Thus, 67 (54 %) of the 124 patients in
the present investigation were slow inactivators and 57 (46 %) were rapid inactivators.
Ratio of urinary excretion of acetylisoniazid to isoniazid : The ratios of the urinary
excretion of acetylisoniazid to isoniazid at various intervals after an intramuscular
injection of isoniazid 3 mg/kg are illustrated on a logarithmic scale in Graphs 2 and 3.
The logarithmic transformation was employed, with success, to equalize the error
variance (that is, the variance between duplicate estimations of the ratio) in the rapid
inactivators and the slow inactivators.
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Graph 1
Distribution of 241 patients according to the serum isoniazid concentration,
4½ h after an intramuscular dose of 3 mg/kg body-weight
3
Isoniazid concentration (µg/ml)
The concentration was < 0.20 µg/ml in 16 patients
The ratio in the first hour collection failed to separate the patients into two dis-
tinct groups (Graph 2) and is therefore not considered further in this report.Con-
sidering the ratios for the periods 1-2, 2-3 and 3-4 h (Graph 2), and for O-2 h
(Graph 3), the distributions clearly indicate the presence of two distinct groups of
patients – namely, the slow inactivators (left side) and the rapid inactivators (right
side). The geometric mean ratio and the range for the two groups of patients are pre-
sented in Table I, together with the criterion for classifying a patient as slow inactivator.
It will be seen that the critical ratio increases with increasing period after the test dose.
The classification based on each of the urinary ratios (1-2, 2-3, 3-4, 0-2 h) and that
based on the standard microbiologic method employing serum were identical for every
patient.
The last column of the Table provides an index of the efficiency with which each
of the urinary ratios discriminates between slow and rapid inactivators of isoniazid
–the larger the index, the more efficient is the discrimination. The indices for the
ratios at 2-3 and 3-4 h are similar, and were of the same order as the index (untabula-
ted) obtained with the standard microbiologic method on the same set of patients.
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Graph 2
Distributions of patients according to the ratio of acetylisoniazid to isoniazid inurine
for the periods 0-l, 1-2, 2-3 and 3-4 h
Log. 10 x Ratio of acetylisoniazid to isoniazid
Graph 3
Distribution of patients according to the ratio of acetylisoniazid to
isoniazid in urine for the period 0-2 h
!
Log. 10 x Ratio of acetylisoniazid to isoniazid
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It will also be noticed that the indices for the ratios at 1-2 and 0-2 h are slightly
smaller than the indices for the ratios at 2-3 and 3-4 h.
Table I. Ratio of urinary excretion of acetylisonlazid to isoniazid after an intramuscular dose
of isoniazid 3 mg/kg body-weight
Period (hours)
after test dose
Slow inactivators Rapid inactivators






l - 2 0.74 0.44–1.11 2.19 1.36–5.45 <1.26 24.1
2 - 3 0.89 0.47–1.40 3.16 1.82–6.32 <1.58 27.4
3 - 4 1.02 0.43–1.56 4.47 2.48–10.76 <2.00 27.8
0 - 2 0.71 0.45–1.09 1.78 1.30–2.94 < 1.12 24.2
*The difference in means between slow and rapid inactivators, divided by the standard error of the
difference
Heterogeneity among rapid inactivators :Graph 4 correlates the serum isoniazid
concentration at 4½ h with the ratio of the urinary excretion of acetylisoniazid to
isoniazid for the period 3-4 h.T e scattergram demonstrates a clear distinction
between the slow inactivators and the rapid inactivators. Also, within the rapid
inactivators, it is possible to identify 8 patients (marked as x), all of whom had very
low serum isoniazid concentrations (<0.2 µg/ml) and very high urinary ratios (> 6.3).
All eight patients are included in the group of 9 patients (also marked as x) who can be
identified from Graph 5 as having a high ratio for the period 2-3 h (>4.0) and for the
period 3-4 h (>6.3).Finally, the ratios for the period 1-2 h for these eight patients
were all higher than the corresponding ratios for the remaining patients. These
findings demonstrate that there was heterogeneity among the rapid inactivators,
and that there were probably 8 or 9 homozygous rapid inactivators in the population
examined in the present study.
Stability of isoniazid and acetylisoniazid in urine :From each of 27 patients (14 slow
inactivators, 13 rapid inactivators), collections were made of the total urine excreted
during the period 24-26 h after an oral dose of a slow-release preparation of iso-
niazid (35 mg/kg) or soluble isoniazid (15 mg/kg), and estimations of isoniazid and
acetylisoniazid were undertaken.After adding a crystal of thymol as a preservative,
aliquots of the 27 specimens were stored at 37°C and the estimations repeated at
2, 4, 7, 10 and 14 days.The mean isoniazid content for the 27 patients showed a signi-
ficant linear decline (P< 10-5), the reduction being 8 % by 7 days and 15 % by 14 days
(Table II). In contrast, the mean acetylisoniazid content did not appear to be affected
by the storage. Further analyses, not tabulated here, showed that the classification
as slow or rapid inactivator was not altered for any patient as a result of the loss in
isoniazid content from storage.
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Graph 4
Correlation between serum isoniazid concentration at 4½ h and ratio of acetylisoniazid
to isoniazid in urine for the period 3-4 h
RAPID
Log. 10 x Ratio of acetylisoniazid to isoniazid in urine













*Mean of the values for 27 samples
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Graph 5
Correlation between the value-s of the ratio of acetylisoniazid to isoniazid
in urine for the periods 2-3 and 3-4 h
Discussion
The methods commonly used for determining the rate of inactivation of isoniazid
consist in measuring the plasma/serum concentrations of the drug 6 h after oral
dosage (Evans et al 1960, 1961, Mukoyama et l 1963, Sunahara et al 1961), the serum
ealf-life of the drug after intravenous or intramuscular injection (Jenne 1960, Scott
et al 1969, Tiitinen 1969), or the serum isoniazid concentration 4½ h after intra-
muscular injection (Gangadharam et l 1961, Tuberculosis Chemotherapy Centre,
Madras 1970).The isoniazid inactivation rate can also be determined by measuring
the percentage of acetylated sulphadimidine in plasma/blood or urine 6-8 h after an
oral dose of sulphadimidine (Evans 1969, Rao et al 1970).
This paper describes a method for classifying subjects as slow or rapid inactivators
by measuring the ratio of the urinary excretion of acetylisoniazid to isoniazid for the
periods 0-2, 1-2, 2-3 or 3-4 h after an intramuscular dose of isoniazid 3 mg/kg body-
weight. There was 100 % agreement between the classification based on each of the
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above ratios and that based on a standard microbiologic method employing serum.A
further study of the efficiency of each of these ratios in discriminating between slow
and rapid inactivators (Table I) suggested that acollec ion of urine over the period
0-2 h would be very satisfactory ;also, that no major extra benefit would be derived
(a) by asking the subject to empty his bladder at 1 h and collecting only the urine
excreted during 1-2 h, or (b) by collecting the urine excreted during 2-3 or 3-4 h.
The above method of classification, based on the ratio of acetylisoniazid to iso-
niazid in a 0-2 h collection of urine, has several advantages.First, it does not re-
quire the collection of blood, unlike many of the earlier methods. Secondly, the
period of waiting is reduced to 2 h for the subject, and the test result can be made
available the same day. Lastly, since the classification is based on a ratio, the ac-
curacy of the method is unlikely to be affected by the failure to obtain a complete urine
collection. A disadvantage of the method, however, is that the test dose has to be
administered by intramuscular injection.Another limitation, especially under field
conditions, is the instability of isoniazid in urine.In the present study, storage at 37°C
reduced the isoniazid content by 8 % in 7 days and by 15 % in 14 days, despite the
addition of a crystal of thymol as a preservative. However, this did not alter the classi-
fication (as slow or rapid) in any instance.
It is difficult to differentiate clearly between homozygous and heterozygous
rapid inactivators of isoniazid on the basis of the isoniazid half-life after an oral or
intramuscular dose of the drug (Scott et al 1969). In the present study, scattergrams
relating the ratio of acetylisoniazid to isoniazid in urine for the period 3-4 h with
the corresponding ratio for the period 2-3 h and with the serum isoniazid concentration
at 4½ h suggested the presence of a group of 8 or 9 homozygous rapid inactivators.It
is of interest that, according to the Hardy-Weinberg law, the expected number of
homozygous rapid inactivators in the population under study is 8.
Since the completion of this study, a method has been described by Russell (1970)
for classifying subjects as slow or rapid inactivators by measuring, semi-quantitatively,
the ratio of acetylisoniazid to isoniazid in a specimen of morning urine obtained after
oral dosage with 300 mg of isoniazid in 3 divided doses (after meals) on the previous
day. Although such a method might be technically convenient, it is unlikely to be very
practicable under field conditions.More recently, Eidus et al (1971) have described
a method similar to ours, but collecting the urine over the period 6-8 h after an
intramuscular test dose of isoniazid 8 mg/kg.
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